Skip to main content
Clinical Trials/CTRI/2018/04/013157
CTRI/2018/04/013157
Active, not recruiting
未知

A randomised placebo-controlled clinical study to assess the safety and tolerability of Capsifen and its efficacy on energy expenditure

Akay Flavours and Aromatics Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Akay Flavours and Aromatics Private Limited
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Akay Flavours and Aromatics Private Limited

Eligibility Criteria

Inclusion Criteria

  • 1\)Male or female healthy volunteers who have been practicing exercise or training
  • sessions for a minimum period of last 1 month to manage the obesity
  • 2\)Age 21\-40 Years ( Both Inclusive)
  • 3\)Subjects with Body Mass Index (BMI) between 27Kg/m to 40 Kg/m
  • 4\)Shall agree to sign an Informed Consent Document

Exclusion Criteria

  • 1\)Subject with history of cardiovascular, Type 2 Diabetes mellitus, pulmonary, hepatic, gastrointestinal problems, and renal problems
  • 2\)Subjects with a history of anorexia nevosa or other eating disorders
  • 3\)Subjects with known history of gastrointestinal irregularities
  • 4\)Prior use of anti obesity agents
  • 5\)History of surgical therapy for obesity
  • 6\)Subjects with known genetical syndromes which cause obesity
  • 7\)Subjects who are currently under any kind of long term medication
  • 8\)Subjects with a known allergy to herbal products
  • 9\)Subjects with abnormal biochemical or haematological values
  • 10\)Pregnant or Lactating Women

Outcomes

Primary Outcomes

Not specified

Similar Trials